oxymetazoline has been researched along with Arterial Occlusive Diseases in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magargal, LE | 1 |
| Sanborn, GE | 1 |
| Donoso, LA | 1 |
| Gonder, JR | 1 |
1 other study available for oxymetazoline and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Branch retinal artery occlusion after excessive use of nasal spray.
Topics: Adult; Arterial Occlusive Diseases; Humans; Imidazoles; Male; Nasal Decongestants; Oxymetazoline; Re | 1985 |